SOD1 and amyotrophic lateral sclerosis: Gene silencing therapy is an effective treatment for amyotrophic lateral sclerosis (ALS) patients carrying mutations in the superoxide dismutase‐1 (SOD1) gene aiming to reduce noxious forms of SOD1 in the central nervous system (CNS).